$AMTM

Amentum Q3 FY2026 Results: Adj. EPS Beats at $0.67, Backlog Surges to $48.2 Billion

Amentum Holdings (NYSE: AMTM) reported Q3 FY2026 adjusted diluted EPS of $0.67, above the $0.61 consensus, while revenue was $3.49B, below the $3.57B estimate. Net income rose to $66M and free cash flow reached $135M. Backlog increased to $48.2B. The company raised FY2026 adjusted EBITDA and adjusted EPS guidance but trimmed revenue outlook.

Original reporting
Published Aug 10, 2026, 9:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amentum Q3 FY2026 Results: Adj. EPS Beats at $0.67, Backlog Surges to $48.2 Billion — source image
Decision brief

The 30-second read

$AMTMNeutralMed
01

Why it matters

The key tradable update is the combination of a Q3 adjusted EPS beat, a revenue miss, and an FY2026 guidance update that raises Adjusted EBITDA and EPS while revising revenue outlook lower versus consensus.

02

Market read

Traders can reassess forward expectations using the updated FY2026 Adjusted EBITDA and Adjusted EPS ranges, while monitoring the revenue guidance shortfall versus consensus.

03

What to watch

Backlog rose to $48.2B with net bookings and book-to-bill >1, which may offset revenue caution if conversion timing improves; also free cash flow strength may support valuation despite top-line softness.

Relevance 8/10Novelty 8/10Timing: after-hours guidance update and Q3 print (published 2026-08-10 21:58 UTC)

Background

Amentum is an advanced engineering and technology services provider with two segments: Digital Solutions and Global Engineering Solutions.

Company-level read

Ticker impact

$AMTMNeutralMedium confidence
Context

Amentum reported Q3 FY2026 adjusted EPS of $0.67 (beat) and raised FY2026 Adjusted EBITDA and EPS guidance despite revenue missing estimates.

Expected impact

Likely two-sided reaction: upside from EPS/EBITDA guide raise, offset by revenue range cut versus consensus.

Evidence & confidence

The article provides both the beat (EPS) and the updated FY2026 ranges, including revenue guidance below analyst consensus, which typically drives mixed positioning into the next earnings window.

Market effects

Defense and advanced engineering services investors may reprice near-term revenue visibility versus margin resilience.

Primarily US-listed defense services sentiment; limited direct regional spillover described.

Backlog and nuclear/space-related contract wins can influence broader government-services procurement expectations.

Counterpoint

The revenue miss and lower sales guidance could dominate the narrative even with EPS/EBITDA raises, implying margin may not be repeatable if contract transitions slow.

Key entities

  • Amentum Holdings, Inc.

    Reported Q3 FY2026 results and updated FY2026 guidance, including adjusted EPS and revenue ranges.

  • NASA

    Mentioned as a customer via the COSMOS contract and CMOE II IDIQ contract.

  • U.S. defense and allied military operations

    Mentioned as a source of over $1B in classified defense engineering, logistics, and modernization awards.

Related articles

$AMTMMed

Why Amentum (AMTM) Shares Are Trading Lower Today

Amentum Holdings (NYSE: AMTM) shares fell about 6% after the company’s Q3 results missed Wall Street expectations. Revenue was $3.49B, down 2% and below the $3.57B consensus. GAAP EPS was $0.27, also below estimates. Backlog rose 8.1% y/y, but investors focused on weaker revenue and profit.

$AMTMMedAI 8/10

Amentum Reports Third Quarter Fiscal Year 2026 Results

Amentum Holdings (NYSE: AMTM) reported third-quarter FY2026 revenue of $3.49 billion, down 2% year over year. Net income was $66 million, with adjusted EBITDA of $290 million and adjusted diluted EPS of $0.67. Operating cash flow was $146 million and free cash flow $135 million. Backlog rose to $48.2 billion, with book-to-bill of 1.1x.